Lung Ultrasound Speeds Up VAP Diagnosis and Improves ICU Outcomes

journals.ekb.eg October 20, 2025

This prospective randomized controlled study investigated whether using Lung Ultrasound (LUS) as a primary bedside tool for diagnosing Ventilator-Associated Pneumonia (VAP) could outperform the standard radiological approach and improve patient outcomes.

VAP is a dangerous ICU-acquired infection that significantly increases morbidity, mortality, and costs.

Lung ultrasound is a reliable, safe, and accurate bedside tool for the early detection and monitoring of VAP.

Its ability to enable earlier intervention leads to demonstrably improved clinical outcomes for critically ill, mechanically ventilated patients.

126 mechanically ventilated adult patients were randomized into two groups (63 in each): a Control Group diagnosed using standard Chest X-ray/CT, and a Lung Ultrasound (LUS) Group diagnosed primarily with daily LUS monitoring.

The LUS group achieved a VAP diagnosis significantly earlier than the control group (5.08 days vs. 6.35 days, p<0.001).